ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Alvarez Named New President of The Society of Gynecologic Oncology; Society Restructures

April 13, 2012

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

NCAB Opposes Line Item for Centers

May 23, 1980

Clinical Research Needs Payment Mechanism, Kerrey

February 4, 1994

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002